menopause and glp 1 Let’s talk about GLP-1 medications in the context of perimenopause menopause, because this is where the conversation most often gets flattened into something it is not. This is not about vanity, Menopause Hormone Therapy May Boost

The phase 3 data arrived later and from an unusual source: the REDEFINE 1 trial, which included a cagrilintide 2.4 mg monotherapy arm alongside CagriSema, semaglutide 2.4 mg and placebo across 3,417 adults with obesity or overweight and at least one comorbidity, without type 2 diabetes

Imbalances in H2S due to gut dysbiosis may lead to Crohns disease, IBS, ulcerative colitis, SIBO, obesity, and sepsis

5,6 Figure 1 shows side by side the results of the four cardiovascular outcome studies with long-acting GLP-1RAs and is in keeping with a class effect for this group of agents

When food enters the gastrointestinal tract, GLP-1 is released into the bloodstream in response to nutrient intake, particularly carbohydrates and fats